Topical Management of arterial and venous ulcers - VascularWeb

More documents

Recommendations

Info

Why debride?• Presence of non-viable/necrotic tissue atwound edge prevents migration of newepithelium to cover wound• Debridement results in recruitment ofplatelets, release of PDGF, other plateletderivedfactors– Converts chronic wound to acute wound
Special considerations forpatients with ulcers and CLI• When to debride?• How much?• What about eschar?
Page 1 and 2: Professor of Surgery Chief, Divisio
Page 3 and 4: DisclosuresScientific Consultant•
Page 6 and 7: Venous/lymphatic ulcer• Common as
Page 8 and 9: • May be inatypicallocations• T
Page 10: Causes of Atypical WoundsInfectious
Page 13 and 14: When to biopsy a• Long durationch
Page 15 and 16: Rx protocol for VLU• Compression
Page 17 and 18: Coexistent arterial insufficiency:H
Page 19: Topical therapy• Wound debridemen
Page 23 and 24: How much to debride?
Page 25 and 26: The necrotic toe
Page 27 and 28: Wound bacterial load• Bacterial c
Page 29 and 30: Biofilm/bacterial burden
Page 31 and 32: Wound bacteria data - chronicVLU•
Page 33 and 34: Vulcan trial• Michaels et al Br J
Page 35 and 36: What to put on the wound?• Over 5
Page 37 and 38: Demonstrated effects of chronicwoun
Page 39 and 40: Exudate Management:DressingsNone Lo
Page 41 and 42: Hydrocolloids• Provide barrier if
Page 43 and 44: Foams, Specialty absorbents• High
Page 45 and 46: Negative pressure compared tomoist

Topical Management of arterial and venous ulcers - VascularWeb

Create successful ePaper yourself

Delete template?

Save as template?